Code | 1483E | ||||||||||
MA number | 21/0192/22-S | ||||||||||
Product Form: | tbl 14x25 mg (blis.PVC/Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Neuraxpharm Bohemia s.r.o., Czechia | ||||||||||
Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister PVC/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 30.07.2022 |
Validity: | 30.07.2027 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
PIL: |
|
SPC: |
|
Safety feature | Unknown |
Data update: | 31.05.2024 |